Skip to content
10-Q

Quarterly Report

AngioDynamics, Inc. ANGO

0001275187-25-000010

← back to feed
Filed
Apr 2, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Apr 1, 2025 40.61M sh
Cash And Equivalents Q3 2025 · Feb 28, 2025 $44.76M
Cash And Equivalents Q3 2025 · May 31, 2024 $76.06M
Current Liabilities Q3 2025 · Feb 28, 2025 $77.97M
Current Liabilities Q3 2025 · May 31, 2024 $91.16M
Total Liabilities Q3 2025 · Feb 28, 2025 $99.55M
Total Liabilities Q3 2025 · May 31, 2024 $112.09M
Current Assets Q3 2025 · Feb 28, 2025 $172.27M
Current Assets Q3 2025 · May 31, 2024 $193.25M
Total Assets Q3 2025 · Feb 28, 2025 $285.42M
Total Assets Q3 2025 · May 31, 2024 $317.67M
Shares Diluted Q3 2025 · Feb 29, 2024 40.23M sh
Shares Diluted Q3 2025 · Feb 29, 2024 40.1M sh
Stock Repurchased Q3 2025 · Feb 29, 2024 $0
Capex Q3 2025 · Feb 29, 2024 $1.95M
Operating Cash Flow Q3 2025 · Feb 29, 2024 −$33.16M
Stockholders Equity Q3 2025 · Feb 29, 2024 $218.7M
Stockholders Equity Q3 2025 · Nov 30, 2023 $401.23M
Stockholders Equity Q3 2025 · Aug 31, 2023 $427.8M
Stockholders Equity Q3 2025 · May 31, 2023 $378.3M
Eps Diluted Q3 2025 · Feb 29, 2024 −$4.67
Eps Diluted Q3 2025 · Feb 29, 2024 −$4.26
Eps Basic Q3 2025 · Feb 29, 2024 −$4.67
Eps Basic Q3 2025 · Feb 29, 2024 −$4.26
Sga Expense Q3 2025 · Feb 29, 2024 $10.58M
Sga Expense Q3 2025 · Feb 29, 2024 $30.72M
Rd Expense Q3 2025 · Feb 29, 2024 $8.19M
Rd Expense Q3 2025 · Feb 29, 2024 $24.79M
Net Income Q3 2025 · Feb 29, 2024 −$187.74M
Net Income Q3 2025 · Feb 29, 2024 −$170.9M
Net Income Q3 2025 · Nov 30, 2023 −$29.05M
Net Income Q3 2025 · Aug 31, 2023 $45.88M
Operating Income Q3 2025 · Feb 29, 2024 −$199.9M
Operating Income Q3 2025 · Feb 29, 2024 −$177.99M
Gross Profit Q3 2025 · Feb 29, 2024 $35.86M
Gross Profit Q3 2025 · Feb 29, 2024 $116.18M
Cost Of Revenue Q3 2025 · Feb 29, 2024 $39.32M
Cost Of Revenue Q3 2025 · Feb 29, 2024 $116.75M
Revenue Q3 2025 · Feb 29, 2024 $75.18M
Revenue Q3 2025 · Feb 29, 2024 $232.93M